Loading...

BEI: Future Product Rollouts Will Drive Upside Despite Sector Headwinds

Published
07 Nov 24
Updated
02 Dec 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-24.7%
7D
6.1%

Author's Valuation

€116.5819.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 02 Dec 25

Fair value Decreased 0.27%

BEI: Wider Market Expansion Will Sustain Core Performance Through Execution Challenges

Beiersdorf's analyst price target has been trimmed slightly, down from €116.89 to €116.58. Analysts highlight concerns over slower brand growth and product launch risks, while maintaining cautious optimism for the stock's core performance.

Analyst Commentary

Recent analyst activity reflects a mix of optimism and caution surrounding Beiersdorf's future performance. Valuation adjustments and rating shifts highlight both the strengths and challenges perceived in the company's outlook.

Bullish Takeaways
  • Bullish analysts emphasize Beiersdorf's ability to maintain core operational strength, even while navigating new product launches and market shifts.
  • Recent adjustments to price targets, though downward, still reflect a level of confidence in the company's overall growth potential and resilience.
  • Analysts projecting an Overweight or Buy stance point to the company's strategic initiatives and global sell-in plans as supportive of medium-term revenue growth.
  • Continued support for major brands and ongoing innovation, including epigenetic product launches, are viewed as catalysts that could reinvigorate topline performance.
Bearish Takeaways
  • Bearish analysts highlight that reduced price targets indicate concerns about slower-than-expected brand growth and execution risk.
  • There are specific worries about the company's ability to meet growth expectations with Nivea, which has shown stalled organic sales year to date.
  • The risk of planned product launches cannibalizing existing business is cited as a headwind for sustaining core revenue streams.
  • Some analysts have downgraded the stock's rating, suggesting that challenges in maintaining high single-digit growth rates could weigh on near-term valuation.

Valuation Changes

  • Consensus Analyst Price Target has decreased modestly, moving from €116.89 to €116.58.
  • Discount Rate has risen slightly, from 5.36 percent to 5.40 percent.
  • Revenue Growth expectations remain nearly flat, with a minor change from 3.30 percent to 3.30 percent.
  • Net Profit Margin has edged down, shifting from 10.61 percent to 10.60 percent.
  • Future Price-to-Earnings Ratio has dipped slightly, from 25.49x to 25.47x.

Key Takeaways

  • Science-driven product innovation and premiumization are boosting brand equity and enabling profitable growth in both premium and mass-market skincare segments.
  • Expansion in emerging markets and advances in digital transformation are increasing market reach and supporting sustainable revenue and margin improvements.
  • Increased competition, market uncertainty, retailer pressures, and rising costs are constraining Beiersdorf's growth, pricing power, and profitability across core and premium segments.

Catalysts

About Beiersdorf
    Manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia.
What are the underlying business or industry changes driving this perspective?
  • Breakthrough innovation in science-based skincare, particularly the global rollout of the Epicelline anti-aging ingredient under both Eucerin and NIVEA, positions Beiersdorf to capture increased demand from an aging, health-conscious population, driving higher-margin revenue growth from both premium and mass-market channels.
  • Strategic expansion in emerging markets-illustrated by Eucerin's successful entry and strong growth in China and India-capitalizes on rising middle class purchasing power and urbanization, expanding Beiersdorf's addressable market and providing a runway for sustained organic revenue growth.
  • Aggressive pivot towards premiumization and premium science-backed offerings (e.g., NIVEA Epigenetics Serum, Derma Control deodorant, Thiamidol range) enables higher average selling prices, improved consumer repurchase rates, and supports gross margin expansion over the long term.
  • Accelerating digital transformation in marketing, distribution, and direct-to-consumer approaches, especially in China and across e-commerce, is enhancing brand equity, increasing ROI on marketing spend, and supporting both top-line growth and operating leverage.
  • Recent resolution of retailer delistings and pricing negotiations in Europe, combined with a robust innovation/launch pipeline in H2 and broader geographic relistings, is expected to yield a rebound in sales volumes and positively impact near-term revenue and profit margins.

Beiersdorf Earnings and Revenue Growth

Beiersdorf Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Beiersdorf's revenue will grow by 3.8% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 8.9% today to 10.8% in 3 years time.
  • Analysts expect earnings to reach €1.2 billion (and earnings per share of €5.42) by about September 2028, up from €882.0 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as €952 million.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 26.3x on those 2028 earnings, up from 24.3x today. This future PE is greater than the current PE for the GB Personal Products industry at 24.3x.
  • Analysts expect the number of shares outstanding to decline by 0.82% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 5.52%, as per the Simply Wall St company report.

Beiersdorf Future Earnings Per Share Growth

Beiersdorf Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Intensifying competition from local brands and private labels, particularly in emerging markets and mass market segments, is eroding NIVEA's volume growth and market share, which could lead to lower revenues and compressed pricing power over the long term.
  • Weaker-than-anticipated market growth in key regions (notably emerging markets and Eastern Europe), combined with volatile demand and consumer caution, is slowing Beiersdorf's top-line organic growth and undermining long-term revenue expansion.
  • Persistent retailer pressure in Europe-evidenced by delistings, heightened demands for price reductions, and delayed relistings-suggests that Beiersdorf's pricing strategies may negatively affect shelf presence and sales volumes, risking downward pressure on revenue and net margins if retailer relations do not stabilize.
  • Ongoing underperformance in the luxury La Prairie segment and slow progress in building scale for premium brands in the US and travel retail reduce anticipated margin expansion and leave Beiersdorf vulnerable to market headwinds in high-margin categories, dragging on overall group profitability.
  • Rising costs due to innovation-driven marketing investments, the need to overinvest in digitalization and e-commerce, ongoing regulatory changes (such as US/Swiss tariffs), and unfavorable foreign exchange effects are collectively raising the cost base faster than sales growth, resulting in only modest---or flat---net earnings and jeopardizing margin improvement in the medium to long term.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of €124.737 for Beiersdorf based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €180.0, and the most bearish reporting a price target of just €98.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €11.0 billion, earnings will come to €1.2 billion, and it would be trading on a PE ratio of 26.3x, assuming you use a discount rate of 5.5%.
  • Given the current share price of €98.0, the analyst price target of €124.74 is 21.4% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Beiersdorf?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives